Related Experiment Videos
Substitution therapy for heroin addiction.
James Bell1, Alain Dru, Benedikt Fischer
1The Langton Centre, Sydney, NSW, Australia. jamesb@sesahs.nsw.gov.au
Substance Use & Misuse
|August 16, 2002
Summary
Substitution treatment for heroin addiction, using opioid agonist drugs, is growing. Key challenges include balancing access with diversion control, integrating primary care, and overcoming stigma, which impacts policy stability.
Area of Science:
- Addiction Medicine
- Public Health Policy
- Pharmacology
Background:
- Substitution treatment for heroin addiction has seen increased utilization over the past decade.
- This treatment involves the maintenance prescribing of opioid agonist drugs for opioid-dependent individuals.
- The review examines the recent history and critical issues surrounding this treatment modality in five countries.
Purpose of the Study:
- To review the recent history of substitution treatment in Canada, the U.K., Australia, Israel, and France.
- To identify and analyze the critical issues common to substitution treatment across these nations.
- To explore the challenges related to accessibility, diversion, primary care integration, and stigma.
Main Methods:
- A review of the recent history of substitution treatment in five selected countries.
- Analysis of critical issues concerning accessibility, diversion, and primary care involvement.
- Examination of the impact of stigma on treatment policy and community support.
Main Results:
- Common critical issues identified across all five countries include balancing treatment accessibility with diversion prevention.
- There is a trend towards increased primary health care involvement in delivering opioid agonist maintenance treatment (OMT), though with some ambivalence.
- Stigma associated with addiction and OMT significantly strains the treatment system and makes it vulnerable to policy changes.
Conclusions:
- Substitution treatment faces similar challenges globally, particularly concerning access, diversion, and the role of primary care.
- Overcoming stigma is crucial for the sustainability and effectiveness of opioid agonist maintenance treatment.
- Policy stability for substitution treatment is threatened by societal values and political shifts.